NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.
about
NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
NMDA receptor antagonism with ...... on in a rat model of epilepsy.
@ast
NMDA receptor antagonism with ...... on in a rat model of epilepsy.
@en
type
label
NMDA receptor antagonism with ...... on in a rat model of epilepsy.
@ast
NMDA receptor antagonism with ...... on in a rat model of epilepsy.
@en
prefLabel
NMDA receptor antagonism with ...... on in a rat model of epilepsy.
@ast
NMDA receptor antagonism with ...... on in a rat model of epilepsy.
@en
P2093
P2860
P356
P1433
P1476
NMDA receptor antagonism with ...... ion in a rat model of epilepsy
@en
P2093
Elham Amini
Fadihl L Faraj
Hussin A Rothan
Rohana Yusof
Teow Chong Teoh
P2860
P2888
P356
10.1038/SREP45540
P407
P577
2017-03-30T00:00:00Z